[go: up one dir, main page]

HK1001670B - Oral composition - Google Patents

Oral composition Download PDF

Info

Publication number
HK1001670B
HK1001670B HK98100745.1A HK98100745A HK1001670B HK 1001670 B HK1001670 B HK 1001670B HK 98100745 A HK98100745 A HK 98100745A HK 1001670 B HK1001670 B HK 1001670B
Authority
HK
Hong Kong
Prior art keywords
cetylpyridinium chloride
teeth
adsorption
amino acid
salt
Prior art date
Application number
HK98100745.1A
Other languages
German (de)
French (fr)
Chinese (zh)
Other versions
HK1001670A1 (en
Inventor
Ohtsuki Hidehiko
Fujita Tomomi
Original Assignee
Sunstar Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2139125A external-priority patent/JPH0684294B2/en
Application filed by Sunstar Kabushiki Kaisha filed Critical Sunstar Kabushiki Kaisha
Publication of HK1001670B publication Critical patent/HK1001670B/en
Publication of HK1001670A1 publication Critical patent/HK1001670A1/en

Links

Description

FIELD OF THE INVENTION
The present invention relates to the use of cetylpyridinium and an Nα-longer acyl basic amino acid lower alkyl ester or salt thereof for the preparation of a composition for the oral cavity, wherein adsorption of cetylpyridinium chloride as a bactericide to the surfaces of teeth is promoted.
BACKGROUND OF THE INVENTION
Dental plaque is formed by adsorption and propagation of intraoral bacteria such as Streptococcus mutans and the like on the surfaces of teeth. It is well known that dental plaque is the cause of dental caries and is also the cause of gingivatis or alveolar pyorrhea. Therefore, it is important to remove dental plaque and to prevent adhesion of it (plaque control) for oral sanitation.
Among the plaque control methods, the method which is conducted most popularly is that for removing dental plaque mechanically by brushing, that is, by using a toothbrush. However, in order to remove dental plaque completely by brushing, high-level brushing technique is needed. In practice, almost all of peoples are conducting insufficient brushing and, therefore, the rate of diseases such as dental caries, gingivatis and alveolar pyorrhea is not reduced despite of conducting brushing.
Accordingly, in order to compensate brushing, or to substitute for brushing, a chemical plaque control method has been studied. The pyridinium compounds having C₈₋₁₈ straight or blanched chain alkyl group are famous. Among them, the compound of which efficacy and safety are clinically admitted is cetylpyridinium chloride.
It is known that cetylpyridinium chloride is a compound represented by the formula: and it has a bactericidal action and is relatively liable to be adsorbed to oral mucosa or the surfaces of teeth. Thereby, it is considered that adsorption of intraoral bacteria to the surfaces of teeth is prevented and, further, formation of dental plaque is prevented. However, a study on promoting adsorption of such cetylpyridinium chloride to the surfaces of teeth and improving it's effect has not been found yet.
EP-A 0422 803 and EP-A 0 924 222 disclose an oral composition comprising cetylpyridinium chloride as an antibacterial agent and Nα-cocoyl-L-arginine ethyl ester pyrrolidone carboxylate as a cationic surfactant. GB-A 132 420 describes the antimicrobial and germicidal properties of lower alkyl esters of mono-N-higher aliphatic acyl arginine.
The present inventors have intensively studied to promote remaining of cetylpyridinium chloride in the oral cavity, particularly adsorption of it to the surfaces of teeth and to enhance the effect for preventing formation of bacterial plaque. As a result, it has been found that, when cetylpyridinium chloride is used in combination with an Nα-longer acyl basic amino acid lower alkyl ester or a salt thereof, adsorption of cetylpyridinium chloride to the surfaces of teeth is extremely promoted. Thus, the present invention has been completed.
DISCLOSURE OF THE INVENTION
According to the present invention, there is provided an oral composition comprising cetylpyridinium chloride and a Nα-longer acyl basic amino acid lower alkyl ester or a salt thereof. According to the present invention, an oral composition which promotes adsorption of cetylpyridinium chloride to the surfaces of teeth and has excellent effect for preventing formation of dental plaque and dental caries can be obtained.
Cetylpyridinium chloride is normally formulated into the composition in an amount of more than 0.002 % by weight, preferably more than 0.01 % by weight. In view of bactericidal effect, the upper limit of the amount of cetylpyridinium chloride is not specifically limited. Considering the fact that cetylpyridinium chloride has a bitter taste and is likely to color teeth when the amount is too large, or influence on oral mucosa and the like, it is normally preferred that the amount is less than 1 % by weight.
As the basic amino acid part of the Nα-longer acyl basic amino acid lower alkyl ester to be used, ornithine, lysine and arginine are particularly preferred and it may be either an optical isomer or laceme thereof. The acyl group thereof is a saturated or unsaturated natural or synthetic fatty acid residue having 8 to 22 carbon atoms, for example, it may be a natural system mixed fatty acid residue such as coconut oil fatty acid, tallow fatty acid residue and the like, in addition to a monofatty acid residue such as lauroyl, myristyl, stearoyl group and the like. Further, it may also be a lower alkyl ester, and methyl ester, ethyl ester and propyl ester are suitable.
Examples of the salt of such the Nα-longer basic amino acid lower alkyl ester include an inorganic acid salt such as hydrochloride, sulfate, etc. or an organic acid salt such as acetate, tartrate, citrate, p-toluenesulfonate, fatty acid salt, acidic amino acid salt, etc. Among them, glutamate, pyroglutamate, acetate and citrate are preferred.
In the present invention, the Nα-longer basic amino acid lower alkyl ester or a salt thereof is that which promotes adsorption of cetylpyridinium chloride to the surfaces of teeth. The weight ratio thereof is at least 1/5, normally 1/5 to 10 based on the weight of cetylpyridinium chloride. When the ratio is too small, an effect for promoting adsorption of cetylpyridinium chloride to teeth becomes insufficient.
The oral composition of the present invention can be prepared in the form of tooth powder, dentifrice, mouthwash, troches and the like by formulating desired ingredients according to a conventional method and, further, it can be sprayed in the oral cavity as an aerosol. Further, it can be used for a liniment and also used after it was impregnated in a dental floss or toothpick.
The other ingredients formulated may be any ingredients which can be used in this kind of compositions in so far as they do not inhibit adsorption of cetylpyridinium chloride to the surfaces of teeth and it's bactericidal action. In the case of using vesicants or solubilizers, anionic ingredients are not preferred. It has been found that, when using nonionic or cationic ingredients, particularly, polyoxyethylene polyoxypropylene glycol, ethylenediaminetetrapolyoxyethylene polyoxypropylene glycol and the like, the effect of cetylpyridinium chloride is further improved.
EXAMPLES
In Experiments and Examples, all percentages are by weight unless otherwise stated.
Experiment 1 Adsorption test of cetylpyridinium chloride to the surfaces of teeth
The composition of enamel of the surfaces of teeth consists of inorganic mineral (97 %), organic material (1%) and water content (2 %), and a main ingredient of the mineral is calcium phosphate which is referred to as hydroxyapatite [Ca₁₀(PO₄)₆(OH)₂].
As a model of enamel of teeth, that obtained by dipping a hydroxyapatite disc [Bio-Gel HTP manufactured by Bio. Rad. Laboratories Co., U.S.A., 13 mmφ x 250 mg; prepared by making tablets at 150 kg/cm² and sintering at 600°C for 6 hours] in human saliva at 37°C for 18 hours was used. By dipping in saliva, saliva mucoprotein, etc. was adsorbed to the surface of hydroxyapatite to be allowed to simulate an actual state of tooth enamel wetted with saliva. This hydroxyapatite disc treated with saliva was placed in a test tube, followed by the addition of an aqueous 0.05 % cetylpyridinium chloride (manufactured by Merck Co.) solution (1 ml) and shaking at 37°C for 30 minutes. Thereafter, it was washed with water (6 ml) and extracted with an extraction solvent [50 mM sodium lauryl sulfate, 40 mM citrate buffer (pH 3.0)/acetonitrile = 30/70] to form a sample for high speed liquid chromatography. In the case of high speed liquid chromatography, Lichrosorb RP select B (4.0 mmφ x 250 mm) was used as a separation column and a extraction solvent was used as an eluent. The flow rate was 1 ml/minutes and detection of cetylpyridinium was conducted by measuring absorbance with 258 nm. Further, by using a calibration curve made by a standard solution of cetylpyridinium chloride, the amount of cetylpyridinium chloride was determined.
Likewise, after an apatite disc treated with saliva was dipped in a mixed solution in which various additives as shown in Table 1 were added to 0.05 % cetylpyridinium chloride in an amount of 0.1 %, respectively, the amount of cetylpyridinium chloride was determined. Further, regarding Nα-cocoyl-L-arginine ethyl ester pyrrolidone carboxylate among the additives which showed the effect for enhancing the amount of cetylpyridinium chloride adsorbed on the apatite disc, by varying in amount between 0.005, 0.01 and 0.05 %, respectively, the influence of the concentration on the amount of cetylpyridinium chloride adsorbed was confirmed. The results are also shown in Table 1. Table 1
Compound Amount of cetylpyridinium chloride (»g/disc)
Initial After 3 hours
0.05 % Cetylpyridinium chloride 170 63
411 321
436 336
438 346
424 330
59 18
173 60
175 119
331 242
392 294
As is shown in Table 1, when a Nα-longer acyl basic amino acid lower alkyl ester is formulated, cetylpyridinium chloride is specifically adsorbed to the hydroxyapatite disc and it is necessary that the weight ratio is more than 1/5 based on the weight of cetylpyridinium chloride.
Experiment 2
Since cetylpyridinium chloride is sometimes inactivated in the case of forming a salt with an acidic substance, retention of bactericidal activity was also tested as follows.
Regarding a sample wherein adsorption of cetylpyridinium chloride to the hydroxyapatite disc was enhanced by adding the Nα-longer acyl basic amino acid lower alkyl ester, a disc was suspended to a 5 % sucrose BHI medium. Then, one loopful of the Streptococcus mutans ATCC 25175 strain was inoculated and cultivated at 37°C for 18 hours. As a result, adhesion of plaque to the hydroxyapatite disc was not observed and it was confirmed that cetylpyridinium chloride adsorbed on the hydroxyapatite disc retains bactericidal activity.
Example 1
According to the following formulation, a toothpaste was prepared by degassing, kneading and stirring according to a conventional method.
Ingredients % by weight
Calcium hydrogenphosphate 20.0
Polyoxyethylene polyoxypropylene glycol 30.0
Glycerin 10.0
Cetylpyridinium chloride 0.1
0.05
Saccharin sodium 0.2
Flavor 1.0
Distilled water up to 100 %
Example 2
According to the following formulation, a toothpaste was prepared by degassing, kneading and stirring according to a conventional method.
Ingredients % by weight
Calcium carbonate 35.0
Hydroxyethylcellulose 1.5
Ethylenediamine tetrapolyoxyethylene polyoxypropylene glycol 5.0
Sorbitol 30.0
Cetylpyridinium chloride 0.01
0.01
Saccharin sodium 0.1
Flavor 1.0
Distilled water up to 100 %
Example 3
According to the following formulation, a liquid mouthwash was prepared by mixing with stirring according to a conventional method.
Ingredients % by weight
Ethanol 10.0
Glycerin 10.0
Polyoxyethylene polyoxypropylene glycol 1.5
Saccharin sodium 0.02
Cetylpyridinium chloride 0.05
0.1
Flavor 0.3
Distilled water up to 100 %
Example 4
A yarn of 630 deniers comprising a plural of fine denier filaments of 6,6-nylon being twisted was dipped in the mixed solution of the following formulation, passed through a drying tube at 50°C and spooled with vaporizing ethanol to produce a dental floss.
Ingredients % by weight
Cetylpyridinium chloride 5.0
10.0
Ethanol 85.0

Claims (1)

  1. Use of cetylpyridinium chloride and an Nα-C₈ to C₂₂ acyl basic amino acid methyl, ethyl or propyl ester or salt thereof for the preparation of an oral composition, whereby the Nα-C₈ to C₂₂ acyl basic amino acid methyl, ethyl or propyl ester or salt thereof promotes the adsorption of said cetylpyridinium chloride to the surface of the teeth.
HK98100745A 1990-05-29 1991-05-23 Oral composition HK1001670A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2139125A JPH0684294B2 (en) 1990-05-29 1990-05-29 Oral composition
JP139125/90 1990-05-29
PCT/JP1991/000691 WO1991018585A1 (en) 1990-05-29 1991-05-23 Oral composition

Publications (2)

Publication Number Publication Date
HK1001670B true HK1001670B (en) 1998-07-03
HK1001670A1 HK1001670A1 (en) 1998-07-03

Family

ID=15238097

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98100745A HK1001670A1 (en) 1990-05-29 1991-05-23 Oral composition

Country Status (15)

Country Link
US (1) US5266306A (en)
EP (1) EP0485616B1 (en)
JP (1) JPH0684294B2 (en)
KR (1) KR0167019B1 (en)
CN (1) CN1069189C (en)
AT (1) ATE126051T1 (en)
AU (1) AU633217B2 (en)
CA (1) CA2060895C (en)
DE (1) DE69111985T2 (en)
DK (1) DK0485616T3 (en)
ES (1) ES2078523T3 (en)
GR (1) GR3017090T3 (en)
HK (1) HK1001670A1 (en)
MY (1) MY106151A (en)
WO (1) WO1991018585A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI942765L (en) * 1991-12-11 1994-06-10 Procter & Gamble Cetylpyridinium chloride and domiphene bromide in an organic solvent
CN1034417C (en) * 1992-12-04 1997-04-02 福州人造板厂 Urea-formaldehyde resin for middle density fibre board use and preparing process
CN1112592C (en) * 1994-08-05 2003-06-25 阿波罗·阿尔杰布拉(直布罗陀)有限公司 Tactile-acoustic information detection and measurement device and method
GB9611364D0 (en) * 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
US5948390A (en) * 1997-08-25 1999-09-07 Pfizer Inc. Stable zinc/citrate/CPC oral rinse formulations
US5874068A (en) * 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
KR100308247B1 (en) * 1999-03-12 2001-09-26 신창국 Compositions for cleaning oral cavity
KR100630512B1 (en) * 2000-06-13 2006-09-29 주식회사 엘지생활건강 Mouthwash Composition for the Prevention and Treatment of Colds and Sore throat
WO2002031105A1 (en) * 2000-10-12 2002-04-18 Sapporo Immuno Diagnostic Laboratory Method and instrument for collecting fluid in the oral cavity
CN100403005C (en) 2001-04-20 2008-07-16 札幌免疫诊断研究所 Device for sampling and recovering oral secretion
CA2455983C (en) 2001-08-09 2010-06-01 Joan Baptista Urgell Beltran Preservative systems and their use in cosmetic preparations
US8388986B2 (en) 2001-08-09 2013-03-05 Laboratorios Miret S.A. Use of cationic surfactants in cosmetic preparations
PT1437946E (en) 2001-10-25 2012-07-25 Miret Lab USE OF A COTTON PRESERVE IN FOOD PRODUCTS
CA2467244C (en) * 2001-11-15 2011-01-04 Laboratorios Miret S.A. Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care
US6579513B1 (en) 2002-01-03 2003-06-17 Playtex Products, Inc. Hygiene mouthspray composition
ATE408702T1 (en) 2002-02-01 2008-10-15 Miret Lab ENZYMATIC SYNTHESIS OF N(ALPHA)-ACYL-L-ARGININE ESTERS
MXPA04010976A (en) 2002-05-08 2005-01-25 Miret Lab New preservatives and protective systems.
US6669929B1 (en) 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
US6946119B2 (en) * 2003-02-14 2005-09-20 J.M. Huber Corporation Precipitated silica product with low surface area, dentifrices containing same, and processes
US20040258632A1 (en) * 2003-06-23 2004-12-23 Boyd Thomas J. Stable aqueous antiplaque oral compositions
US8287843B2 (en) 2003-06-23 2012-10-16 Colgate-Palmolive Company Antiplaque oral care compositions
EP1635774B2 (en) 2003-06-23 2011-01-26 Colgate-Palmolive Company Stable dentifrice compositions
US20040258629A1 (en) * 2003-06-23 2004-12-23 Boyd Thomas J. Antiplaque confectionery dental composition
DK1663122T3 (en) * 2003-06-23 2010-06-07 Colgate Palmolive Co Mouthwash compositions containing N-acyl-arginine alkyl ester salts
US9241885B2 (en) * 2004-01-29 2016-01-26 The Procter & Gamble Company Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials
US20070014740A1 (en) * 2005-07-15 2007-01-18 Colgate-Palmolive Company Oral compositions having cationic active ingredients
US20080260836A1 (en) * 2007-04-18 2008-10-23 Thomas James Boyd Films Comprising a Plurality of Polymers
MY154018A (en) 2008-02-08 2015-04-30 Colgate Palmolive Co Dental floss
WO2012008410A1 (en) 2010-07-12 2012-01-19 花王株式会社 Toothpaste composition
CN102416011A (en) * 2011-10-10 2012-04-18 艾硕特生物科技(昆明)有限公司 Broad-spectrum and high-efficiency antibacterial lotion
EP4106716B1 (en) 2020-02-18 2026-01-28 Sunstar Americas, Inc. Oral care composition

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL104948C (en) * 1952-02-15
US2772203A (en) * 1952-04-03 1956-11-27 Colgate Palmolive Co Stable dental creams containing higher aliphatic acyl amide of aminocarboxxylic acid compound
US2757125A (en) * 1952-05-16 1956-07-31 Colgate Palmolive Co N-higher alkyl-4-carboxy-2-pyrrolidones and compositions therewith
US2772204A (en) * 1954-09-13 1956-11-27 Colgate Palmolive Co Dental preparations containing higher aliphatic acyl sarcoside compounds
US2909535A (en) * 1955-03-15 1959-10-20 Colgate Palmolive Co Novel higher aliphatic acid derivatives and compositions containing the same
US2842479A (en) * 1955-05-24 1958-07-08 Colgate Palmolive Co Nu-higher aliphatic acyl alpha-amino aryl acetic acids and compositions therewith
GB1352420A (en) * 1971-06-18 1974-05-08 Ajinomoto Kk Arginine derivatives their production and their use
US4080441A (en) * 1976-12-27 1978-03-21 Colgate-Palmolive Company Antibacterial oral composition
AU578392B2 (en) * 1984-07-31 1988-10-20 Lion Corporation Toothpaste composition containing silica
JPS61126010A (en) * 1984-11-20 1986-06-13 Lion Corp Composition for oral cavity application
JPH0720854B2 (en) * 1986-02-20 1995-03-08 ライオン株式会社 Oral composition
JPH085773B2 (en) * 1986-09-02 1996-01-24 ライオン株式会社 Oral composition
LU86587A1 (en) * 1986-09-15 1988-04-05 Oreal TOOTHPASTE CONTAINING A POLY NON-IONIC SURFACTANT (HYDROXYPROPYLETHER) AND A SALT OF A SPECIFIC DERIVATIVE OF A PROTEIN DEGRADATION PRODUCT
DE68914386T2 (en) * 1988-10-20 1994-11-17 Ajinomoto Kk Toothpaste-like composition.
JPH0825861B2 (en) * 1989-04-24 1996-03-13 サンスター株式会社 Toothpaste composition
NZ235498A (en) * 1989-10-11 1993-05-26 Beecham Group Plc Dentifrice comprising cationic antibacterial agent, non-ionic thickener, surfactant and an abrasive consisting of a sparingly soluble salt and/or an insoluble compound
GB9008433D0 (en) * 1990-04-12 1990-06-13 Beecham Group Plc Novel compositions

Similar Documents

Publication Publication Date Title
EP0485616B1 (en) Oral composition
HK1001670B (en) Oral composition
US5286479A (en) Oral compositions for suppressing mouth odors
EP0169888B1 (en) Dental rinse
EP0256566B1 (en) Use of usnic acid or derivatives thereof in the treatment of dental caries
JP2011201861A (en) Composition for oral cavity
EP0510158B1 (en) Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and metal salts
HU201464B (en) Process for producing solution for rinsing mouth and comprising edta-sodium salt as active ingredient
JP5688882B2 (en) Liquid oral composition
US4477429A (en) Oral compositions comprising N.sup.α -alkyl derivatives of arginine
JPH09286712A (en) Composition for oral cavity
US4499068A (en) Oral compositions comprising NG -alkyl derivatives of arginine
JP4452601B2 (en) Liquid oral composition
EP0976380B1 (en) Method of recalcifying teeth
JP2548265B2 (en) Oral hygiene medicine
JP2022103980A (en) Composition for oral cavity
KR100637653B1 (en) Oral composition for bad breath
JP3117086B2 (en) Oral liquid preparation
JPH0684293B2 (en) Oral composition
JPS61200905A (en) Composition for oral cavity application
JP3702428B2 (en) Liquid oral composition
WO1990010434A1 (en) Dental preparation
JPH0627062B2 (en) Oral composition
JP2848696B2 (en) Oral liquid preparation
JPH05331032A (en) Composition for oral cavity